Products Antibodies Polyclonal Antibodies KD Validated Anti-NDUFA13/GRIM19 Polyclonal Antibody for WB, ELISA - Q9P0J0
KD Validated Anti-NDUFA13/GRIM19 Polyclonal Antibody for WB, ELISA - Q9P0J0

Polyclonal Antibodies

KD Validated Anti-NDUFA13/GRIM19 Polyclonal Antibody for WB, ELISA - Q9P0J0

Item Number : CM0025457

Price varies based on specs and customizations


Application
WB, ELISA
Cross Reactivity
Human, Mouse, Rat
Protein Weight
17kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name [KD Validated] NDUFA13/GRIM19 Rabbit pAb
Remarks/Alias B16.6; CDA016; CGI-39; GRIM19; GRIM-19; MC1DN28; [KD Validated] NDUFA13/GRIM19
Species Human
GeneID (human) 51079
GeneID 51079
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 1-144 of human NDUFA13/GRIM19 (NP_057049.5)
Source Rabbit
Category Polyclonal Antibodies
Application WB, ELISA
Cross Reactivity Human, Mouse, Rat
SWISS Q9P0J0
Protein Weight 17kDa
Shipping Ice bag

Biological Background: NDUFA13/GRIM19 Function and Localization

  • NDUFA13/GRIM19 is an accessory subunit of mitochondrial membrane respiratory chain Complex I that is not directly involved in catalysis, but is essential for electron transfer from NADH to ubiquinone. Related references: PMID:27626371
  • It mediates interferon/all-trans-retinoic acid (IFN/RA)-induced apoptosis, and its apoptotic activity is inhibited by interaction with viral IRF1.
  • The protein prevents transactivation of STAT3 target genes and plays a role in CARD15-mediated innate mucosal responses, regulating intestinal epithelial cell responses to microbes. Related references: PMID:15753091
  • Subcellular localization includes the mitochondrial inner membrane and the nucleus.
  • Widely expressed, with highest levels in heart, skeletal muscle, liver, kidney, and placenta; down-regulated in intestinal mucosa areas affected by Crohn disease and ulcerative colitis.
  • Post-translational modifications include acetylation; the gene undergoes alternative splicing.
  • Key associated terms: primary mitochondrial disease, host-virus interaction, and apoptosis.

Experimental Guidance and Technical Tips

  • The immunogen covers the N-terminal region (aa 1-144) of NDUFA13/GRIM19, a region containing known functional domains – this design may favor recognition of native conformations in Western blot (WB) and ELISA.
  • In WB, expect a band at approximately 17 kDa (predicted molecular weight 16.7 kDa plus potential modifications); validate specificity using knockdown (KD) or knockout models when available.
  • For ELISA, consider pairing this polyclonal antibody with a matched monoclonal capture or detection antibody; perform cross-reactivity and matrix effect assessments in the relevant sample system.
  • Note that the antibody reportedly reacts with human, mouse, and rat samples; verify species-specific performance in your assay conditions.
  • Optimization of dilution factors and incubation conditions is recommended based on the specific experimental model.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio serves as a one-stop sourcing partner for IVD raw materials, technical services, and consulting—from concept to clinic. This NDUFA13/GRIM19 antibody supports research in mitochondrial biology, apoptosis, and inflammatory diseases. We supply validated antibody pairs, optimized monoclonal and polyclonal antibodies, bulk ancillary reagents, and can assist in sourcing rare-target raw materials to streamline your diagnostic development.

View more faqs for this product

Product Datasheet

KD Validated Anti-NDUFA13/GRIM19 Polyclonal Antibody for WB, ELISA - Q9P0J0


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!